@Cryptob41792251 @noriega_dr For instance https://t.co/Vn4efvpWD0 “At data cutoff, 230 (33%) patients had died”
@iescolar Lo que sí es cierto es que los pacientes con neoplasias hematológicas, especialmente aquellos con mayor edad, neoplasia no controlada o ciertos biomarcadores presentan una mortalidad especialmente elevada. https://t.co/QIHm0WU39L https://t.co/2VD
@anthonymatomd @MartinTallman @sloan_kettering Why only 250 patients have been included so far in the #COVID19 @ASH_hematology Collaborative Data Hub? We have collected over 800 patients with hematological malignancies only in #Madrid 🇪🇸 👉 https://t.co/Mzf
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. #lymphoma #lymsm https://t.co/MM5ZtB1st5
RT @biblioGetafe: 👉👉Impact of hematologic malignancy and type of cancer therapy on #COVID_19 severity and mortality: lessons from a large p…
👉👉Impact of hematologic malignancy and type of cancer therapy on #COVID_19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol 13, 133 (2020). https://t.co/x3ei2ht6lx @hematologiamadr y Laurentino Benito-Parra del
Un buen trabajo colaborativo del impacto de #COVID19 en Pacientes Hematológicos en Madrid...@sehh_es https://t.co/exgYzxdILl
RT @DrRaulCordoba: #OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons fro…
RT @DrRaulCordoba: #OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons fro…
RT @DrRaulCordoba: #OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons fro…
RT @DrRaulCordoba: #OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons fro…
RT @DrRaulCordoba: #OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons fro…
#OncoAlert “Impact of hematologic malignancy and type of #cancer therapy on #COVID19 severity and mortality: lessons from a large population-based registry study” #hematology Kudos to @jgarciasu59 & @hematologiamadr https://t.co/MzfVNHm899
RT @adrianalegrea: Un buen trabajo colaborativo del impacto de #COVID19 en Pacientes Hematológicos en Madrid...@sehh @hematologiamadr @fleu…
Un buen trabajo colaborativo del impacto de #COVID19 en Pacientes Hematológicos en Madrid...@sehh @hematologiamadr @fleucemiaylinfo “Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https:
RT @NicoGagelmann: Important collaborative effort from @hematologiamadr on impact of hematologic malignancy and type of therapy on COVID-1…
RT @NicoGagelmann: Important collaborative effort from @hematologiamadr on impact of hematologic malignancy and type of therapy on COVID-1…
Important collaborative effort from @hematologiamadr on impact of hematologic malignancy and type of therapy on COVID-19 severity/mortality: -#AML strongly associated with worse outcome -mortality for transplanted patients "only" 18% #leusm #bmtsm https
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. #lymphoma #lymsm https://t.co/MM5ZtB1st5
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https://t.co/7JFpUR6Zli
RT @UAI_imas12: Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https:…
New article: Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. https://t.co/T19vhUVZ7e #AML #leusm #hematology https://t.co/HmTvU84GEF
RT @UAI_imas12: Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https:…
RT @UAI_imas12: Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https:…
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a larg… https://t.co/AAdiQIXrEl @jmartinezlo @bvh12o @jmesltradal @Invecuid_h12o #imas12 #Hospital12Octubre #COVID19 #CANCER